Purchase of Rapid Syndromic Molecular Testing Reagents for Seattle VAMC
Key Takeaways
- Set-aside for No Set Aside businesses
- Work to be performed in VANCOUVER, WA
- Industry: In-Vitro Diagnostic Substance Manufacturing
Contract Details
- Notice ID
- 36C26026Q0960
- Opportunity Type
- Solicitation
- Sub-Agency
- VETERANS AFFAIRS, DEPARTMENT OF
- Office
- 260-NETWORK CONTRACT OFFICE 20 (36C260)
- Posted Date
- Wednesday, August 19, 2026
- Response Deadline
- Thursday, September 10, 2026
- PSC Code
- 6515
- Set-Aside
- No Set Aside
- Place of Performance
- VANCOUVER, WA, 98661
- Status
- Active
Description
Our scope is to acquire specific FDA-approved infectious disease and oncology assays formulated as single-use test cartridges and reagents that are equal to and/or compatible to what is currently being used on the VA owned instrument/analyzer. Required rapid molecular assays include targets for C. difficile, SARS-CoV-2 with Influenza A & B and RSV, Strep A, MTB IVD Mycobacterium tuberculosis with Rif, MVP-Multiplex Vaginal Panel, GI Panel, MRSA Carba-R, Norovirus, BCR-ABL, FII & FV and vanA PCR. The kit storage temperature should be 2 28C and not require refrigeration. Time and date of delivery to be determined by the PSHCS Microbiology Department.
Why This Opportunity Matters
VETERANS AFFAIRS, DEPARTMENT OF is actively seeking qualified contractors for in-vitro diagnostic substance manufacturing with a set-aside for No Set Aside businesses in VANCOUVER, WA. This set-aside designation means eligible businesses face reduced competition from larger firms.
Similar Opportunities
Browse Related
Looking for more opportunities?
Browse our full directory of government contracts